XML 101 R84.htm IDEA: XBRL DOCUMENT v3.3.1.900
Compensation Plans - Others (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Feb. 02, 2015
USD ($)
$ / shares
shares
Feb. 03, 2014
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
item
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
shares
Dec. 31, 2013
USD ($)
$ / shares
shares
Termination          
Deferred compensation cost | $     $ 19.0    
Employee Benefit Plan          
Matching contribution by Company, maximum percentage of participant's eligible compensation (as a percentage)     4.00%    
Matching contributions to Employee Benefit Plan | $     $ 1.0 $ 1.0 $ 1.0
Common Stock Options          
Shares Authorized under Stock Option Plan Exercise Price Range          
Shares under Options (in shares) | shares     1,738,000    
Weighted Average Exercise Price (in dollars per share)     $ 38.58    
Currently Exercisable - Shares Under Options (in shares) | shares     1,368,000    
Currently Exercisable - Weighted Average Exercise Price (in dollars per share)     $ 37.88    
Share-based Compensation Arrangement by Share-based Payment Award, Options Unvested          
Unvested at the beginning of the period (in shares) | shares     906,000    
Vested (in shares) | shares     (512,000)    
Forfeited (in shares) | shares     (24,000)    
Unvested at the end of the period (in shares) | shares     370,000 906,000  
Unvested at the beginning of the period, weighted average grant date fair value (in dollars per share)     $ 4.85    
Vested, weighted average grant date fair value (in dollars per share)     5.06    
Forfeited, weighted average grant date fair value (in dollars per share)     4.58    
Unvested at the end of the period, weighted average grant date fair value (in dollars per share)     $ 4.59 $ 4.85  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Information          
Granted (in shares) | shares     0    
Granted, weighted average grant date fair value (in dollars per share)       $ 3.80 $ 5.89
Total vesting date intrinsic values (at vesting) of shares under options vested | $     $ 1.0 $ 7.0 $ 12.0
Total intrinsic value of vested shares under options at the end of the period | $     5.0    
Proceeds received from options exercised | $     28.0 5.0 18.0
Total intrinsic value (at exercise) of options exercised | $     $ 10.0 $ 3.0 $ 25.0
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology          
Implied volatility traded option on common stock period     30 days    
Risk-free rate (as a percent)       1.34% 0.78%
Expected life (in years)       4 years 6 months 4 years 6 months
Expected volatility (as a percent)       22.90% 28.90%
Expected dividend yield (as a percent)       5.40% 5.80%
Restricted Stock and Performance Restricted Stock Units          
Stock-based awards, vesting period     10 years    
Restricted Stock and Performance Restricted Stock Units          
Restricted Stock and Performance Restricted Stock Units          
Performance restricted stock unit is convertible into common stock (in shares) | item     1    
Shares withheld to offset tax withholding obligations (in shares) | shares     200,000 323,000 242,000
Unvested restricted stock and performance restricted stock units activity          
Weighted-average remaining vesting period of restricted stock and restricted stock units     1 year    
Total fair values (at vesting) of restricted stock and restricted stock units vested | $     $ 21.0 $ 24.0 $ 22.0
Restricted stock          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology          
Risk-free rate (as a percent)     0.33% 0.22%  
Expected volatility (as a percent)     17.94% 21.74%  
Expected dividend yield (as a percent)     4.79% 5.61%  
Unvested restricted stock and performance restricted stock units activity          
Unvested at the beginning of the period (in shares) | shares     112,000    
Vested (in shares) | shares     (76,000)    
Unvested at the end of the period (in shares) | shares     36,000 112,000  
Unvested at the beginning of the period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 38.69    
Vested, Weighted Average Grant Date Fair Value (in dollars per share)     37.26    
Unvested at the end of the period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 41.77 $ 38.69  
Restricted Stock Units          
Unvested restricted stock and performance restricted stock units activity          
Unvested at the beginning of the period (in shares) | shares     900,000    
Granted (in shares) | shares     402,000    
Vested (in shares) | shares     (409,000)    
Forfeited (in shares) | shares     (26,000)    
Unvested at the end of the period (in shares) | shares     867,000 900,000  
Unvested at the beginning of the period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 40.54    
Granted, Weighted Average Grant Date Fair Value (in dollars per share)     48.56    
Vested, Weighted Average Grant Date Fair Value (in dollars per share)     44.79    
Forfeited, Weighted Average Grant Date Fair Value (in dollars per share)     43.74    
Unvested at the end of the period, Weighted Average Grant Date Fair Value (in dollars per share)     $ 43.34 $ 40.54  
Minimum | Common Stock Options          
Restricted Stock and Performance Restricted Stock Units          
Stock-based awards, vesting period     3 years    
Minimum | Restricted Stock and Performance Restricted Stock Units          
Restricted Stock and Performance Restricted Stock Units          
Stock-based awards, vesting period     1 year    
Maximum | Common Stock Options          
Restricted Stock and Performance Restricted Stock Units          
Stock-based awards, vesting period     5 years    
Maximum | Restricted Stock and Performance Restricted Stock Units          
Restricted Stock and Performance Restricted Stock Units          
Stock-based awards, vesting period     5 years    
Former Chairman, Chief Executive Officer and President          
Termination          
Severance-related charges | $     $ 27.0    
Accelerated deferred compensation on termination | $     17.0    
Severance payments and other costs | $     $ 10.0    
Three Year LTIP Awards | Minimum          
Unvested restricted stock and performance restricted stock units activity          
Percentage of performance metrics during performance period     0.00%    
Three Year LTIP Awards | Maximum          
Unvested restricted stock and performance restricted stock units activity          
Percentage of performance metrics during performance period     200.00%    
2006 Incentive Plan          
Unvested restricted stock and performance restricted stock units activity          
Granted, Weighted Average Grant Date Fair Value (in dollars per share)   $ 40.68      
Termination          
Total share-based compensation expense recognized | $     $ 26.0 $ 22.0 $ 40.0
Total unrecognized compensation cost, period of recognition     3 years    
2006 Incentive Plan | Three Year LTIP Awards          
Restricted Stock and Performance Restricted Stock Units          
Stock-based awards, vesting period   3 years      
Unvested restricted stock and performance restricted stock units activity          
Granted (in shares) | shares   176,088      
Total fair values (at vesting) of restricted stock and restricted stock units vested | $   $ 7.2      
Weightage Allocated For TSRs Of MSCI US REIT Index   25.00%      
Weightage Allocated For TSRs Of NAREIT Health Care Index   75.00%      
2014 Incentive Plan | Three Year LTIP Awards          
Unvested restricted stock and performance restricted stock units activity          
Granted (in shares) | shares 128,762        
Granted, Weighted Average Grant Date Fair Value (in dollars per share) $ 54.97        
Total fair values (at vesting) of restricted stock and restricted stock units vested | $ $ 6.9        
2014 Incentive Plan | One Year LTIP Award          
Unvested restricted stock and performance restricted stock units activity          
Granted, Weighted Average Grant Date Fair Value (in dollars per share) $ 50.82        
23.34 - 25.52 | Common Stock Options          
Shares Authorized under Stock Option Plan Exercise Price Range          
Exercise Price Range, Lower Range Limit (in dollars per share)     $ 23.34    
Exercise Price Range, Upper Range Limit (in dollars per share)     $ 25.52    
Shares under Options (in shares) | shares     166,000    
Weighted Average Exercise Price (in dollars per share)     $ 23.34    
Weighted Average Remaining Contractual Term     2 years 1 month 6 days    
Currently Exercisable - Shares Under Options (in shares) | shares     166,000    
Currently Exercisable - Weighted Average Exercise Price (in dollars per share)     $ 23.34    
27.11 - 28.35 | Common Stock Options          
Shares Authorized under Stock Option Plan Exercise Price Range          
Exercise Price Range, Lower Range Limit (in dollars per share)     27.11    
Exercise Price Range, Upper Range Limit (in dollars per share)     $ 28.35    
Shares under Options (in shares) | shares     156,000    
Weighted Average Exercise Price (in dollars per share)     $ 28.35    
Weighted Average Remaining Contractual Term     2 years 9 months 18 days    
Currently Exercisable - Shares Under Options (in shares) | shares     156,000    
Currently Exercisable - Weighted Average Exercise Price (in dollars per share)     $ 28.35    
31.95 - 46.92 | Common Stock Options          
Shares Authorized under Stock Option Plan Exercise Price Range          
Exercise Price Range, Lower Range Limit (in dollars per share)     31.95    
Exercise Price Range, Upper Range Limit (in dollars per share)     $ 46.92    
Shares under Options (in shares) | shares     1,416,000    
Weighted Average Exercise Price (in dollars per share)     $ 41.72    
Weighted Average Remaining Contractual Term     4 years 9 months 18 days    
Currently Exercisable - Shares Under Options (in shares) | shares     1,046,000    
Currently Exercisable - Weighted Average Exercise Price (in dollars per share)     $ 41.60